We are live on ! Find out more
FQ

First Quadrant Portfolio holdings

AUM $18M
1-Year Est. Return 24.2%
This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+24.2%
3 Year Est. Return
+90.61%
5 Year Est. Return
+144.35%
10 Year Est. Return
AUM
$4.49B
AUM Growth
+$87.2M
Cap. Flow
-$70.7M
Cap. Flow %
-1.57%
Top 10 Hldgs %
16.01%
Holding
859
New
109
Increased
142
Reduced
182
Closed
54

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$26.9M
2
ELV icon
Elevance Health
ELV
+$26.5M
3
GILD icon
Gilead Sciences
GILD
+$20M
4
ZBRA icon
Zebra Technologies
ZBRA
+$18.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$18M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$27.8M
2
PKG icon
Packaging Corp of America
PKG
+$25.4M
3
AMGN icon
Amgen
AMGN
+$21.4M
4
HSY icon
Hershey
HSY
+$20.5M
5
EIX icon
Edison International
EIX
+$19.8M

Sector Composition

Rank Sector Weight
1 Financials 16.33%
2 Technology 14.8%
3 Healthcare 13.84%
4 Industrials 13.25%
5 Energy 11.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOC icon
51
Northrop Grumman
NOC
$76B
$23.9M 0.53%
199,600
-110,800
-36% -$13.4M
CSCO icon
52
Cisco
CSCO
$443B
$23.5M 0.52%
945,800
+115,400
+14% +$2.75M
WLK icon
53
Westlake Corp
WLK
$9.26B
$22.5M 0.5%
269,200
DST
54
DELISTED
DST Systems Inc.
DST
$22.4M 0.5%
486,200
-1,066
-0.2% -$49K
PG icon
55
Procter & Gamble
PG
$340B
$22.4M 0.5%
284,967
+23,598
+9% +$1.9M
EG icon
56
Everest Group
EG
$15.6B
$22.2M 0.49%
138,425
+21,200
+18% +$3.36M
ALK icon
57
Alaska Air
ALK
$5.11B
$22.1M 0.49%
464,656
VLO icon
58
Valero Energy
VLO
$89.5B
$21.9M 0.49%
437,661
+144,717
+49% +$7.98M
AES icon
59
AES
AES
$10.6B
$21.9M 0.49%
1,408,900
+60,900
+5% +$875K
TSN icon
60
Tyson Foods
TSN
$21.5B
$21.7M 0.48%
578,630
+18,606
+3% +$745K
HUM icon
61
Humana
HUM
$43.9B
$21.2M 0.47%
165,627
+130,500
+372% +$15.5M
WDR
62
DELISTED
Waddell & Reed Financial, Inc.
WDR
$21M 0.47%
335,900
+119,900
+56% +$7.76M
BEN icon
63
Franklin Resources
BEN
$16.8B
$20.8M 0.46%
360,167
-85,100
-19% -$4.66M
M icon
64
Macy's
M
$6.51B
$20.7M 0.46%
356,100
-137,100
-28% -$7.96M
LLY icon
65
Eli Lilly
LLY
$1.08T
$20.3M 0.45%
325,800
-242,500
-43% -$14.5M
PSX icon
66
Phillips 66
PSX
$82.9B
$19.7M 0.44%
244,561
-109,400
-31% -$9.01M
AEP icon
67
American Electric Power
AEP
$70.4B
$19.6M 0.44%
351,200
+276,000
+367% +$14.6M
BRCD
68
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$18.9M 0.42%
2,051,700
+204,500
+11% +$1.88M
RF icon
69
Regions Financial
RF
$26.4B
$18.8M 0.42%
1,772,500
-3,300
-0.2% -$34.4K
EGN
70
DELISTED
Energen
EGN
$18.7M 0.42%
210,000
+165,900
+376% +$14M
CELG
71
DELISTED
Celgene Corp
CELG
$18.5M 0.41%
215,600
BIIB icon
72
Biogen
BIIB
$30.9B
$18.3M 0.41%
58,045
-92,400
-61% -$27.8M
UTHR icon
73
United Therapeutics
UTHR
$26.1B
$18.3M 0.41%
206,600
-44,200
-18% -$4.25M
RKT
74
DELISTED
ROCK-TENN COMPANY CL-A
RKT
$18.3M 0.41%
346,000
IBM icon
75
IBM
IBM
$213B
$18.2M 0.4%
104,910
-14,644
-12% -$2.64M

Similar funds

First Quadrant's Q2 2014 Portfolio in Review

As of Q2 2014, First Quadrant held 859 positions worth $4.49B, up 2% from $4.41B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

First Quadrant's Q2 2014 filing shows 109 new, 142 increased, 182 reduced and 54 closed positions. Its largest new stake was Harley-Davidson: 252,500 shares worth $17.6M. The largest sale was Biogen, an estimated $27.8M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • First Quadrant's largest Q2 2014 buy was Harley-Davidson: 252,500 shares worth $17.6M.
  • First Quadrant added most to Merck in Q2 2014, an estimated $26.9M increase.
  • First Quadrant's biggest Q2 2014 reduction was Biogen, cutting an estimated $27.8M.
  • First Quadrant fully exited BALLY TECHNOLOGIES, INC. in Q2 2014, selling an estimated $14.7M.
  • First Quadrant's ten largest holdings make up 16% of its $4.49B portfolio in Q2 2014.
  • First Quadrant opened 109 new positions and closed 54 in Q2 2014.
  • First Quadrant's portfolio value rose 2% quarter-over-quarter to $4.49B.

Based on First Quadrant's 13F filing for Q2 2014, filed 31 Jul 2014.